A novel method to generate aptamers against recombinant targets displayed on the cell surface.

9Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Isolation of anti-protein aptamers is typically carried out against purified recombinant protein. Thus, certain cell surface proteins including pharmacologically important receptors do not become targets of aptamers due to the difficulties encountered in their purification. In order to overcome this limitation, we developed a new SELEX procedure in which cells displaying the target protein on the cell surface are used, thereby precluding the need for target purification. As a model experiment, CHO cells expressing human transforming growth factor-beta type III receptor (TbRIII) were used as the target for SELEX, resulting in the successful isolation of a specific, high-affinity aptamer.

Cited by Powered by Scopus

Selection of aptamers against live bacterial cells

134Citations
N/AReaders
Get full text

Cell-Selex technology

122Citations
N/AReaders
Get full text

Aptamer applications for targeted cancer therapy

76Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ohuchi, S. P., Ohtsu, T., & Nakamura, Y. (2005). A novel method to generate aptamers against recombinant targets displayed on the cell surface. Nucleic Acids Symposium Series (2004), (49), 351–352. https://doi.org/10.1093/nass/49.1.351

Readers over time

‘09‘11‘12‘14‘15‘17‘19‘21‘2400.751.52.253

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

40%

Researcher 4

40%

Professor / Associate Prof. 2

20%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 5

50%

Biochemistry, Genetics and Molecular Bi... 2

20%

Chemistry 2

20%

Medicine and Dentistry 1

10%

Save time finding and organizing research with Mendeley

Sign up for free
0